Skip to main content


1. Ammann R.W., Muellhaupt B. et al.: The natural history of pain in alcoholic chronic
pancreatitis. Gastroenterol., 1999, 116, 1132-1140.
2. Apte M.V., Haber P.S. et al.: Pancreatic stellate cells are activated by proinflammatory
cytokines: implications for pancreatic fibrogenesis. Gut, 1999, 44, 534-541.
3. Bachem M.G., Schneider E. et al.: Identification, culture and characterization of pancreatic
stellate cells in rats and humans. Gastroenterol., 1998, 115, 421-432.
4. Berney T., Gasche Z. et al.: Serum profiles of IL-6, IL-8 and IL-10 in patients with severe
and mild acute pancreatitis. Pancreas, 1999, 8, 371-377.
5. Cohn J.A., Friedman K.J. et al.: Relation between mutations of the cystic fibrosis gene and
idiopathic pancreatitis. N. Engl. J. Med., 1998, 339, 653-658.
6. Cohn J.A., Jowell P.S.: Are mutations in the cystic fibrosis gene important in chronic
pancreatitis. Surg. Clin. North Am., 1999, 79, 723-734.
7. Corazziari E., Shaffer E.A. et al.: Functional disorders of the biliary tract and pancreas. Gut,
1999, 45 (Suppl. II), 48-54.
8. Dervenis C., Johnson C.D. et al.: Diagnosis, objective assessment of severity, and
management of acute pancreatitis. Int. J. Pancreatol., 1999, 25, 195-210.
9. DiFrancesco V., Brunori M.P. et al.: Comparison of ultrasound-secretin test and sphincter
of Oddi manometry in patients with recurrent acute pancreatitis. Dig. Dis. Sci., 1999, 44,
10. DiMagno E.P.: Toward understanding (and management) of painful chronic pancreatitis.
Gastroenterol., 1999, 116, 1252-1257.
11. Frossard J.L., Saluja A. et al.: The role of intercellular adhesion molecule-1 and
neutrophils in acute pancreatitis and pancreatitis-associated lung injury. Gastroenterol., 1999,
116, 694-701.
12. Gates L.K., Ulrich C.D. et al.: Hereditary pancreatitis. Surg. Clin. North. Am., 1999, 79:,
13. Gorry M.C., Gabbaizedeh D. et al.: Mutations in the cationic trypsinogen gene are
associated with recurrent acute and chronic pancreatitis. Gastroenterol., 1999, 113,

14. Greenberg R., Haddad R. et al.: Continuous intravenous octreotide treatment for acute
experimental pancreatitis. Digestion , 1999, 60, 125-131.
15. Gress F., Schmitt C. et al.: A prospective randomized comparison of endoscopic
ultrasound- and computed tomography-guided celiac plexus block for managing chronic
pancreatitis pain. Am. J. Gastroenterol., 1999, 94, 900-905.
16. Grisham M.B.: NF-κB activation in acute pancreatitis: protective, detrimental, or
inconsequential. Gastroenterol., 1999, 116, 489-492.
17. Hruban R.H., Goggins M. et al.: Molecular genetics and related developments in
pancreatic cancer. Curr. Op. Gastroenterol., 1999, 15, 404-409.
18. Imrie C.W., Menezes N. et al.: Diagnosis of chronic pancreatitis and newer aspects of pain
control. Digestion, 1999, 60(Suppl.1), 111-113.
19. Isaji S., Hayashi J. et al.: Effects of IS-741 (a new synthetic antiinflammatory agent) on
acute necrotizing pancreatitis in dogs. Digestion, 1999, 60 (Suppl.1), 47-51.
20. Jaffe E.M., Schutte M. et al.: Development and characterization of a cytokin-secreting
pancreatic adenocarcinoma vaccine from primary tumors for use in clinical trials. Cancer J.
Sci. Am., 1998, 4, 194-203.
21. Jaffe E.M.: A phase I clinical trial of lethally irradiated allogeneic pancreatic tumor cells
transfected with the GM-CSF gene for the treatment of pancreatic adenocarcinoma. Hum.
Gene Ther., 1998, 9, 978-985.
22. Johnson C.D.: Platelet-activating factor and platelet-activating factor antagonists in acute
pancreatitis. Dig. Surg., 1999, 16, 93-101.
23. Kanwar S.: Early enteral nutrition in acute pancreatitis. Nutrition, 1999, 15, 951-952
24. Karolinska Institute Press Release, 1999: http://www. nobel. se/ announcement-99/
medicine 99. html.
25. Kaufmann P., Smolle K.H. et al.: Relation of serial measurements of plasma-soluble
intercellular adhesion molecule-1 to severity of acute pancreatitis. Am. J. Gastroenterol.,
1999, 94, 2412-2416.
26. Kita K., Saito S. et al.: Growth inhibition of human pancreatic cancer cell lines by
anti-sense oligonucleotides specific to mutated k-
ras genes. Int. J. Cancer., 1999, 80, 553-558.
27. Liang J., Yamaguchi Y. et al.: Novel carboxamide derivative (IS-741) attenuates lung
injury in rats with cerulein-induced pancreatitis complicated by endotoxaemia. Dig. Dis. Sci.,
1999, 44, 341-349.
28. MacFie J., O
,Boyle C. et al.: Gut origin of sepsis: a prospective study investigating
associations between bacterial translocation, gastric microflora, and septic morbidity. Gut,
1999, 45, 223-228.
29. McKenzie I.F.C., Apostolopoulos V.: Towards immunotherapy of pancreatic cancer. Gut,
1999, 44, 767-769.
30. Pemberton L.F., Blobel G. et al.: Transport routes through the nuclear pore complex. Curr.
Opn. Cell Biol., 1998, 10, 392-399.
31. Pezzilli R., Miniero R. et al.: Behavior of serum interleukin 12 in human acute
pancreatitis. Pancreas, 1999, 18, 247-251.
32. Saluja A.K., Steer M.L.: Pathophysiology of pancreatitis. Digestion, 1999, 60 (Suppl.1):
33. Satoh A., Shimosegawa T. et al.: Inhibition of nuclear factor κ activation improves the
survival of rats with taurocholate pancreatitis. Gut, 1999, 44, 253-258.
34. Schmid S.W., Uhl W. et al.: The role of infection in acute pancreatitis. Gut, 1999, 45,
35. Sharer N., Schwarz M. et al.: Mutations of the cystic fibrosis gene in patients with chronic
pancreatitis. N. Engl. J. Med., 1998, 339, 645-652.

36. Steinle A.U., Weidenbach H. et al.: NF-κB/Rel activation in cerulein pancreatitis.
Gastroenterol., 1999, 116, 420-430.
37. Suzuki A., Mizumoto A. et al.: Effect of bacterial or porcine lipase with low- or high-fat
diets on nutrient absorption in pancreatic-insufficient dogs. Gastroenterol., 1999, 116,
38. Talamini G., Bassi C. et al.: Alcohol and smoking as risk factors in chronic pancreatitis
and pancreatic cancer. Dig. Dis. Sci., 1999, 44, 1303-1311.
39. Talamini G., Falconi M. et al.: Incidence of cancer in the course of chronic pancreatitis.
Am. J. Gastroenterol., 1999, 94, 1253-1260.
40. Teich N., Mössner J. et al.: Screening for mutations of the cationic trypsinogen gene: are
they of relevance in chronic alcoholic pancreatitis. Gut, 1999, 44, 413-416.
41. Uhl W., Büchler M.W. et al.: A randomised, double blind, multicentre trial of octreotide
in moderate to severe pancreatitis. Gut, 1999, 45, 97-104.
42. Vaquero E., Molero X. et al.: Myelofibroblast proliferation, fibrosis, and defective
pancreatic repair induced by cyclosporin in rats. Gut, 1999, 45, 269-277.
43. Whitcomb D.C: Early trypsinogen activation in acute pancreatitis. Gastroenterol., 1999,
116, 770-772.